It’s Time to Rethink Heart Failure Research

heart failure patient holding hand to heart
By Nancy Newark, R.N., Executive Director, Project Management, Cardiovascular and Metabolic Diseases, Worldwide Clinical Trials,

  Cardiovascular disease remains the number one killer of men and women in the U.S. While the need for new discovery is high, the reality is that little progress has been made to advance treatments during the past few decades – especially for one of the most serious conditions: heart failure.

Read More

Embrace the Burden! Why Burden-of-Illness Real-World Evidence Studies Are More Important Than Ever

Doctor's Stethoscope and coins
By Jeff Trotter, M.B.A., Senior Vice President, Worldwide Evidence,

  Burden-of-illness real-world evidence studies – initiatives that establish the impact and overall cost of a particular disease from multiple perspectives – have always been important for drug developers, helping them to better understand how to optimally position a new product as a potential solution. That said, there are a number of reasons why it’s never been more critical to undertake burden-of-illness studies. Indeed, characterizing the burden of a particular disease should be viewed as an opportunity, rather than a burden.

Read More

Raise Awareness for Cardiovascular Disease by Taking Part in Wear Red Day

Couple wears red for cardiovascular disease awareness
By Karen Hill, SVP, Project Management, Cardiovascular and Metabolic Diseases,

  The forthcoming National Wear Red Day presents an opportune time to increase public awareness for heart disease, raise money for research, and help keep families together. It can also be the appropriate occasion to introduce or conduct successful cardiovascular research in partnership with a reputable contract research organization.

Read More